Not Clearly Pro or Con to the question "Should Marijuana Be a Medical Option?"
"In a pioneering study, the Beckley Foundation has set-up a collaboration with Prof. Valerie Curran, and Dr. Celia Morgan from the University College London and Harborside Health Centre, Oakland, a leading Californian, city-licensed medical marijuana dispensary. Taking advantage of access to a cohort of over 40,000 patients, this study will investigate the efficacy of cannabis in treating different medical conditions, which has never been attempted before.
We hope over time to build up an extensive database of information gathered through questionnaires, and through analysis of the chemical composition of different strains of cannabis. We plan later to collect information about patients’ genotypes to widen the information-base. Given the variance in the chemical composition of the many different strains of cannabis available to the patients, this will be the first study to analyze the chemical content of individual strains, and to compare the results of cannabis-treatment with treatment by conventional pharmaceutical means, for a wide range of medical conditions. The testing techniques involve the use of gas chromatography, mass spectrometry, flame ionization detection, and plate-culture analysis. The testing programme has two main components: safety screening, and potency quantification. Safety screening will analyze and detect contamination by pathogenic moulds, which can threaten the health of patients with compromised immune systems.
Potency quantification will analyse the percentages of three major active chemical components of cannabis – THC, CBD, and CBN. The study will use extensive online patient surveys to develop a comprehensive database of the efficacy of differing strains of medical cannabis, and will also collect other data on, among other things, the beneficial and detrimental characteristics of the different strains of cannabis. This pioneering study will provide a valuable model for the quantification of the chemical components of different strains of cannabis which could be used in a regulated legal market to minimise harms. The website allowing patients to fill out questionnaires regarding the efficacy of treatment outcomes has just gone online; our aim now is to build the foremost database on the efficacy of different strains of cannabis for the treatment of medical conditions along with their precise chemical composition.
For the first time in the millennia-old history of human cannabis consumption, users will be provided with a scientific assessment of the safety and potency of different stains of cannabis, and also with information about which strains are found to be best for treating which medical conditions."
"The Efficacy of Cannabis for Medical Use," beckleyfoundation.org, Sep. 14, 2010
Organizations/VIPs/Others Individuals and organizations that do not fit into the other star categories.
"The Beckley Foundation is a charitable trust that promotes the scientific investigation of consciousness and its modulation from a multidisciplinary perspective. We also seek to change global drugs policy to reflect a more rational, evidence-based approach, shifting the emphasis from criminalisation to health."
The objects of the Trust are exclusively charitable and are:
(a) to advance the education of the public (by the support of studies, research, including scientific research, and educational activities or otherwise) in the knowledge of human consciousness (meaning the totality of the impressions, thoughts and feelings that make up a person's conscious being) generally and in particular but not exclusively the nature of human consciousness, its relation to human health, influences on human consciousness, changes in human consciousness, how such changes can be and are brought about, the detection, monitoring and observation of human consciousness, changes thereto, and influences thereon, and the science (including the pharmacological, psychological, physiological, biochemical science) of human consciousness and all or any of the foregoing and other facets of human consciousness.
(b) to promote the protection and preservation of public health through the advancement of the education of the public and organisations in the knowledge and understanding (by the support of studies, research, including scientific research, and educational activities or otherwise) of drug policies and drug related issues.
"Beckley Foundation, SC033546," Extract from the Scottish Charity Register, oscr.org.uk, Jan. 8, 2011
Not membership based
£60,718 (fiscal year 2010) [roughly equivalent to $93,651 USD]
Amanda Feilding, Director
# of Offices:
One (Oxford, England)
# of Staff:
All Party Parliamentary Group on Drug Policy, partner
Global Commission on Drug Policy, partner
International Drug Policy Consortium, founder and partner member
International Society for the Study of Drug Policy (ISSDP), founder and partner member